OpenAlex
PricingAboutJobs
Log inGet started
Work

Use of CRISPR/Cas9-engineered INS-1 pancreatic β cells to define the pharmacology of dual GIPR/GLP-1R agonists

HTML

Year: 2016
Type: article
Source: Biochemical Journal
DOI: 10.1042/bcj20160476
Authors: Jacqueline Naylor, Arthur T. Suckow, Asha Seth, David J. Baker, Isabelle Sermadiras, Peter Ravn, Rob Howes, Jianliang Li, Mike R. Snaith, Matthew P. Coghlan, David C. Hornigold
Language: English

Topic: Pancreatic function and diabetes
Subfield: Endocrinology, Diabetes and Metabolism
Field: Medicine
Domain: Health Sciences
Keywords: GIP/GLP-1 receptor agonist, GIP receptor, GLP-1 receptor, pancreatic beta cells, INS-1 cells, CRISPR/Cas9 knockout, receptor selectivity, glucose-stimulated insulin secretion, cAMP signaling, GIP receptor antagonist, diabetes therapeutics
SDG: Good health and well-being

Open Access status: closed

Funder: Directorate for Biological Sciences
OpenAlex ID: W2468343614
FWCI: 3.953
Cites: 26
Cited by: 65
Related to: 10
OpenAlex
Nonprofit
Open DataOpen Data
Open Source
Product
Search
Compare
Pricing
Repositories
Unpaywall
Unsub
Developers
API docs
Data snapshot
Status
Source code
Organization
About
Team
Testimonials
Brand
Jobs
Community
Help center
Contact
Events
Blog
Mailing list
Subscribe
Supporters
Legal
Privacy
Accessibility
Terms
Security